Madagascar, Analamanga (2015)

Madagascar, 2015
Analamanga
Principal Investigator
Hery Harimanitra Andriamanjato
Trainer
Susan Lewallen
RAAB version
RAAB5
Diabetic retinopathy
No
Disability module
No

Vision impairment

Prevalence (age-sex adjusted)

Female
Male
Total
Extrapolated magnitude
%
95% CI
Extrapolated magnitude
%
95% CI
Extrapolated magnitude
%
95% CI
Blind
24
0.7
0.3 - 1.1
14
0.7
0.1 - 1.3
38
0.7
0.4 - 1.0
Severe
29
0.8
0.3 - 1.4
13
0.7
0.1 - 1.2
42
0.8
0.3 - 1.2
Moderate
118
3.4
2.4 - 4.4
42
2.0
1.0 - 3.0
159
2.9
2.1 - 3.7

Cataract

Operable cataract prevalence (age-sex adjusted)

Female
Male
Total
Extrapolated magnitude
%
95% CI
Extrapolated magnitude
%
95% CI
Extrapolated magnitude
%
95% CI
<3/60
7
0.2
0.0 - 0.4
6
0.3
0.0 - 0.6
12
0.2
0.0 - 0.5
<6/60
17
0.5
0.1 - 0.9
7
0.4
0.0 - 0.8
25
0.5
0.1 - 0.8
<6/18
33
1.0
0.4 - 1.5
18
0.9
0.2 - 1.6
51
0.9
0.5 - 1.4

Cataract surgical coverage (CSC) (age-sex adjusted)

Female
Male
Total
%
95% CI
%
95% CI
%
95% CI
CSC<3/60
-
76.3
61.1 - 91.6
-
74.3
59.7 - 59.7
-
75.4
64.4 - 88.3
CSC<6/60
-
55.4
40.0 - 70.9
-
68.9
52.9 - 84.8
-
60.5
43.0 - 67.8
CSC<6/18
-
40.3
28.4 - 52.2
-
47.9
34.7 - 61.0
-
43.2
31.0 - 49.6

Effective cataract surgical coverage (eCSC) (age-sex adjusted)

The RAAB research team are in the process of concluding a formal analysis of eCSC with the World Health Organization and the Vision Loss Expert Group. eCSC results will be available on the repository in 2022.

Notes

Vision impairment categories defined according to WHO thresholds using presenting visual acuity in the better eye.

All prevalence and coverage estimates are adjusted to the age and gender distribution of the population 50 years and older in the survey area.

All 95% confidence intervals adjusted to account for the cluster design of the survey.